Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Experimental and Molecular Pathology|May 21, 2009
ProtEx technology for the generation of novel therapeutic cancer vaccinesRich-Henry Schabowsky, Rajesh K Sharma, Shravan Madireddi, et al.
Plos One|August 8, 2012
SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γShravan Madireddi, Rich-Henry Schabowsky, Abhishek K Srivastava, et al.
Seminars in Immunology|October 7, 2017
The yin and yang of leukotriene B4 mediated inflammation in cancerVenkatakrishna R Jala, Sobha R Bodduluri, Shuchismita R Satpathy, et al.
Plos One|November 13, 2012
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent mannerAbhishek K Srivastava, Rajesh K Sharma, Esma S Yolcu, et al.
Cornea|April 24, 2009
Evaluation of cytotoxic effects of bevacizumab on human corneal cellsKakarla V Chalam, Kakarla V Shalam, Swati Agarwal, et al.
Vaccine|July 7, 2010
SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer modelRajesh K Sharma, Abhishek K Srivastava, Esma S Yolcu, et al.
Cancer Research|May 14, 2009
Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumorsRajesh K Sharma, Kutlu G Elpek, Esma S Yolcu, et al.
Clinical & Experimental Metastasis|December 17, 2015
A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasisRajesh K Sharma, Zinal S Chheda, Biswa Pratim Das Purkayastha, et al.
Plos One|August 4, 2012
Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?Kavitha Yaddanapudi, Robert A Mitchell, Kalyani Putty, et al.
Vaccine|October 20, 2009
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicityRich-Henry Schabowsky, Kutlu G Elpek, Shravan Madireddi, et al.
Pageof 5